Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Lentiviral vector containing the human MYO7A gene

EU orphan designation number: EU/3/10/727   
Active ingredient: Lentiviral vector containing the human MYO7A gene
Indication: Treatment of retinitis pigmentosa in Usher syndrome 1B
Sponsor: Sanofi-Aventis groupe
54 rue La Boétie, 75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/03/2010 Orphan designation EMEA/OD/137/09 (2010)2052 of 23/03/2010
23/06/2014 Transfer of orphan designation EMA/OD/137/09/T/01 (2014)4244 of 19/06/2014
9/06/2015 Transfer of orphan designation EMA/OD/137/09/T/02 (2015)3927 of 5/06/2015